High levels of serum Mac-2-binding protein glycosylation isomer (M2BPGi) predict the development of hepatocellular carcinoma in hepatitis B patients treated with nucleot(s)ide analogues-Reference-Cited by-同舟云学术

High levels of serum Mac-2-binding protein glycosylation isomer (M2BPGi) predict the development of hepatocellular carcinoma in hepatitis B patients treated with nucleot(s)ide analogues

Published:2017-12-29 Issue:7 Volume:53 Page:883-889
ISSN:0944-1174
Container-title:Journal of Gastroenterology
language:en
Short-container-title:J Gastroenterol

Author:

Shinkai Noboru,Nojima Masanori,Iio Etsuko,Matsunami Kayoko,Toyoda Hidenori,Murakami Shuko,Inoue Takako,Ogawa Shintaro,Kumada Takashi,Tanaka Yasuhito

Funder

Research Program on Hepatitis from Japan Agency for Medical Research and Development (AMED) and a grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

http://link.springer.com/article/10.1007/s00535-017-1424-0/fulltext.html

Reference24 articles.

1. Lai CL, Ratziu V, Yuen MF, et al. Viral hepatitis B. Lancet (London, England). 2003;362(9401):2089–94.

2. Chen CJ, Yu MW, Liaw YF. Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol. 1997;12(9–10):S294–308.

3. Liaw YF, Sung JJ, Chow WC, et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med. 2004;351(15):1521–31.

4. Chang TT, Liaw YF, Wu SS, et al. Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B. Hepatology (Baltimore, MD). 2010;52(3):886–93.

5. Marcellin P, Gane E, Buti M, et al. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study. Lancet (London, England). 2013;381(9865):468–75.

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarcadores séricos para la evaluación de la fibrosis hepática;Advances in Laboratory Medicine / Avances en Medicina de Laboratorio;2024-02-14

2. Mac-2 binding protein glycosylation isomer at 5 years of antiviral therapy predict hepatocellular carcinoma and mortality beyond year 5 in chronic hepatitis B patients with cirrhosis;American Journal of Cancer Research;2024

3. Serum biomarkers for liver fibrosis assessment;Advances in Laboratory Medicine / Avances en Medicina de Laboratorio;2023-11-14

4. Diagnostic Performance of Mac 2–Binding Protein Glycosylation Isomer in Chronic Hepatitis B;INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY;2023-07-27

5. Noninvasive assessments of liver disease severity based on biomarkers;Comprehensive Guide to Hepatitis Advances;2023